Karen Kingston

Karen Kingston is a medico-legal advisor and biotech analyst with 25 years experience. Her clients have included Pfizer, Johnson & Johnson, ThermoFisher Scientific, Allergan, Medtronic and other industry titans. As an analyst, she has worked both with start-ups, as well as corporate venture capital firms, including Johnson & Johnson Development Corp. Ms. Kingston internationally recognized as an expert on the harmful biological effects caused by mRNA lipid nanoparticles and other engineered nanoparticle technologies.